Post-approval studies (Phase 4)UnknownNCT06184230What this trial is testingPersistence of Hepatitis A Antibody in Healthy Adults ~32 Years Post Vaccination.Who this might be right forHepatitis A Best Healthcare Inc. 300
Not applicableStudy completedNCT06408519What this trial is testingOpen-Label Placebo for Non-Specific Pain in the EDWho this might be right forPain, Acute Bruno Minotti 57
Large-scale testing (Phase 3)Study completedNCT01896895What this trial is testingEfficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Abnormal Contraction or Twitch of the EyelidWho this might be right forBilateral Blepharospasm (BEB) Merz Pharmaceuticals GmbH 61
Post-approval studies (Phase 4)Looking for participantsNCT03851627What this trial is testingEffects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and HypogonadismWho this might be right forFatty LiverOverweight/ObesityPrediabetes/Type2 Diabetes Mellitus+1 more Alexandra Kautzky-Willer 32
Large-scale testing (Phase 3)Study completedNCT03422653What this trial is testingEvaluate the Safety and Efficacy of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus (KALM-1)Who this might be right forUremic Pruritus Cara Therapeutics, Inc. 378
Post-approval studies (Phase 4)Study completedNCT00219245What this trial is testingAn Extension Study Evaluating the Efficacy and Safety of Rivastigmine in Patients With Traumatic Brain Injury (TBI) With Persistent Cognitive DeficitsWho this might be right forTraumatic Brain Injury With Persistent Cognitive Deficits Novartis 157
Large-scale testing (Phase 3)Active Not RecruitingNCT03105102What this trial is testingThe Efficacy and Safety of Risankizumab in Participants With Crohn's DiseaseWho this might be right forCrohn's Disease AbbVie 1,336
Early research (Phase 1)Study completedNCT05710094What this trial is testingSafety and Tolerability of Single and Multiple Doses of SoftOx Biofilm Eradicator (SBE) in Chronic Leg WoundsWho this might be right forChronic Leg UlcerVenous Leg Ulcer SoftOx Solutions AS 28
Testing effectiveness (Phase 2)Study completedNCT01642212What this trial is testingOBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label ExtensionWho this might be right forEosinophilic Esophagitis (EoE) Shire 93
Large-scale testing (Phase 3)Ended earlyNCT06425159What this trial is testingDetermine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic SeizuresWho this might be right forGeneralized Epilepsy Biohaven Therapeutics Ltd. 27
Large-scale testing (Phase 3)Study completedNCT00540423What this trial is testingClinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)Who this might be right forChronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic GlaxoSmithKline 23
Testing effectiveness (Phase 2)Ended earlyNCT02147873What this trial is testingStudy of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoLWho this might be right forMyelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML) TetraLogic Pharmaceuticals 118
Large-scale testing (Phase 3)Study completedNCT04615273What this trial is testingA Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone DeficiencyWho this might be right forGrowth Hormone DeficiencyEndocrine System DiseasesHormone Deficiency Ascendis Pharma Endocrinology Division A/S 264
Testing effectiveness (Phase 2)Active Not RecruitingNCT05691361What this trial is testingSafety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema PatientsWho this might be right forHereditary Angioedema ADARx Pharmaceuticals, Inc. 53
Early research (Phase 1)Study completedNCT04243083What this trial is testingA Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study of TLL018, With Food Effect, in Healthy ParticipantsWho this might be right forHealthy TLL Pharmaceutical, LLC 100
Early research (Phase 1)Ended earlyNCT01374503What this trial is testingFirst in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4Who this might be right forHealthy Volunteers Ablynx, a Sanofi company 52
Early research (Phase 1)Study completedNCT02541669What this trial is testingA Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese ParticipantsWho this might be right forHealthy Volunteer Takeda 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT05540860What this trial is testingEDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)Who this might be right forDuchenne Muscular Dystrophy Edgewise Therapeutics, Inc. 76
Testing effectiveness (Phase 2)Ended earlyNCT00313261What this trial is testingSafety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo GroupWho this might be right forHepatitis B Bukwang Pharmaceutical
Testing effectiveness (Phase 2)Ended earlyNCT03222973What this trial is testingEfficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS)Who this might be right forMultiple Sclerosis Biogen 263